Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development-Reference-Cited by-同舟云学术

Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development

Published:2020-12-02 Issue:24 Volume:63 Page:15541-15563
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wang Hexiang,Ren Bo,Liu Ye,Jiang Beibei,Guo Yin,Wei Min,Luo Lusong,Kuang Xianzhao,Qiu Ming,Lv Lei,Xu Hong,Qi Ruipeng,Yan Huibin,Xu Dexu,Wang Zhiwei^ORCID,Huo Chang-Xin,Zhu Yutong,Zhao Yuan,Wu Yiyuan,Qin Zhen,Su Dan,Tang Tristin,Wang Fan,Sun Xuebing,Feng Yingcai,Peng Hao,Wang Xing,Gao Yajuan,Liu Yong,Gong Wenfeng,Yu Fenglong,Liu Xuesong,Wang Lai,Zhou Changyou^ORCID

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01346

Reference54 articles.

1. Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints

2. Genome maintenance mechanisms for preventing cancer

3. Perspective on the Pipeline of Drugs Being Developed with Modulation of DNA Damage as a Target

4. A comprehensive look of poly(ADP-ribose) polymerase inhibition strategies and future directions for cancer therapy

5. Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-based approaches in synthetic lethality strategies;Current Opinion in Structural Biology;2024-10

2. Design, synthesis and antitumor activities of phthalazinone derivatives as PARP-1 inhibitors and PARP-1/HDAC-1 inhibitors;Bioorganic Chemistry;2024-10

3. The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer;Medicinal Research Reviews;2024-08-24

4. BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethality;Journal of Clinical Investigation;2024-07-15

5. Design, synthesis, biological evaluation of novel piperidine-based derivatives as potent poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors;Bioorganic Chemistry;2024-07